Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Acquisition

11 Nov 2014 07:00

RNS Number : 6552W
Tarsus Group PLC
11 November 2014
 

11 November 2014

 

Tarsus Group plc

 

Acquisition of the South Beach Symposium

 

Tarsus Group plc (LSE: TRS, "Tarsus" or the "Group"), the international business-to-business media group, has agreed to acquire 100% of the assets of the South Beach Symposium ("SBS") from SBS Medical Education LLC. SBS is a leading educational event for Dermatologists, Plastic Surgeons and other physicians and represents a significant addition to the Group's medical division.

 

The preventative medicine market in the US comprises four key pillars: neurological disorders, endocrinology, cardiovascular and cancer. Skin health is one of the most important elements of preventative medicine with skin cancers now accounting for nearly half of all cancers diagnosed in the United States. SBS' comprehensive approach to skin health education addresses the key areas of dermatology continuing medical education: medical, surgical, including cutaneous oncology, pediatric and aesthetics. Following Tarsus' acquisition earlier this year of a cardiovascular-focused event, the Cardiometabolic Health Congress ("CMHC"), the acquisition of SBS provides the Group with increased access to another key pillar of the US preventative medicine market.

 

In early 2014 the Group broadened its medical education offering with the launch of the Metabolic Medical Institute (MMI). This launch supports the Group's Quickening the Pace strategy which is focused on driving organic growth and making selective strategic acquisitions with a view to accelerating the growth of returns to shareholders. Along with CMHC, the acquisition of SBS accelerates the growth of MMI into the mainstream medical market.

 

Acquisition highlights

 

· Acquisition of 100% of the assets of SBS for a total cash consideration of US$6.4 million (the "Acquisition") with US$5.5 million payable on completion and deferred payments made to be made through to 2018 of US$0.9 million. The consideration will be met from existing financial resources.

· The Acquisition includes the immediate purchase of SBS's planned online education business "Dermatology Education Online" which will take both the existing medical education content of the event as well as new educational and promotional material and make it available to a wider audience online. Consideration for the online education business is payable in 2018 with reference to the profits of that business in 2017. The maximum consideration for the SBS online education business has been set at US$20 million.

· SBS takes place annually in Miami and the next edition will be held in February 2015.

· Founder Mark Nestor, M.D., Ph.D. will continue to lead SBS after its acquisition and is contracted through to the 2017 event.

· For the year ended 31 December 2013, the assets subject to the transaction recorded unaudited profit before tax of approximately US$0.8 million.

· The Acquisition is expected to be earnings accretive in the financial year ending 31 December 2015 and thereafter.

 

 

Douglas Emslie, Tarsus Group Managing Director, said:

 

"The acquisition of SBS is another key step in the transitioning of the Group's medical business and the implementation of the "Quickening the Pace" strategy. As we focus on taking preventative medicine into the mainstream medical market, the acquisition of SBS compliments the launch of MMI and the earlier acquisition of CMHC. These initiatives will accelerate our progress and provide a strong platform for growth".

 

Tarsus is hosting a Capital Markets Seminar for analysts and investors later today to be held at Skinners Hall, 8 1/2 Dowgate Hill, London EC4R 2SP at 4pm. The event will provide information on the Group's Medical division with an overview of the market and the Group's divisional strategy. No new material information will be made available.

 

For further information:

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director

+44 (0)20 8846 2700

Dan O'Brien, Group Finance Director

IR Focus

Neville Harris, Investor Relations

+44 (0)79 0997 6044

 

Notes to editors

 

Tarsus Group plc (LSE:TRS) is an international business-to-business media group with interests in exhibitions, publishing and online media. The Group operates globally in key verticals including aviation, medical, labels and packaging, discount clothing (Off-Price), housewares and automotive. Tarsus runs more than 80 events and websites and its flagship brands include the Labelexpo exhibitions in Europe, the Americas and Asia and the Dubai Airshow.

 

The Group operates across a worldwide network of offices in Dublin, London, Paris, Milwaukee, Boca Raton (Florida), Dubai, Shanghai, Jakarta, New Delhi and Istanbul. Tarsus is building on its strong presence in the emerging markets of the Middle East, China, Turkey, Indonesia and Mexico.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQVBLFFZFFZFBB
Date   Source Headline
30th Jul 20147:00 amRNSHalf Yearly Report
11th Jul 20144:17 pmRNSAdditional Listing and Voting Rights
30th Jun 20145:05 pmRNSDirector/PDMR Shareholding
30th Jun 20145:00 pmRNSTotal Voting Rights
26th Jun 20147:00 amRNSNotice of interim results
24th Jun 20146:01 pmRNSDirector/PDMR Shareholding
24th Jun 201412:03 pmRNSDirectorate Change
23rd Jun 20143:44 pmRNSResult of AGM
20th Jun 20144:17 pmRNSDirector/PDMR Shareholding
5th Jun 20143:35 pmRNSScrip Dividend Circular
21st May 20145:26 pmRNSNotice of AGM
15th May 20147:00 amRNSInterim Management Statement
12th May 20141:00 pmRNSBlocklisting Interim Review
7th May 20147:46 amRNSNotice of IMS
30th Apr 20145:03 pmRNSTotal Voting Rights
24th Mar 20144:26 pmRNSDirector/PDMR Shareholding
18th Mar 20145:15 pmRNSCompletion of acquisition of SIUF
17th Mar 20145:10 pmRNSAnnual Financial Report
12th Mar 20144:35 pmRNSDirector/PDMR Shareholding
5th Mar 20144:15 pmRNSDirector/PDMR Shareholding
4th Mar 20147:00 amRNSFinal Results
26th Feb 201411:41 amRNSNotice of Results
19th Feb 20144:03 pmRNSHolding(s) in Company
13th Feb 201410:11 amRNSAdmission of Placing Shares
10th Feb 201411:08 amRNSCompletion of Placing
10th Feb 20147:00 amRNSProposed Placing of New Ordinary Shares
10th Feb 20147:00 amRNSAcquisitions
23rd Jan 201410:04 amRNSApplication for Admission
8th Jan 20147:01 amRNSCorporate Activity
8th Jan 20147:00 amRNSYear end trading update
19th Dec 20138:41 amRNSScrip Dividend
2nd Dec 20134:55 pmRNSTotal Voting Rights
26th Nov 20137:00 amRNSAcquisition
8th Nov 20132:55 pmRNSBlocklisting Interim Review
4th Nov 20137:00 amRNSInterim Management Statement
30th Sep 201311:13 amRNSTotal Voting Rights
16th Sep 20134:51 pmRNSDirector/PDMR Shareholding
22nd Aug 20137:00 amRNSInterim Financial Report
2nd Aug 20132:59 pmRNSTotal Voting Rights
2nd Aug 20132:58 pmRNSApplication for Admission
31st Jul 20137:01 amRNSDirectorate Change
31st Jul 20137:00 amRNSHalf Yearly Report
28th Jun 201311:35 amRNSTotal Voting Rights
28th Jun 20137:00 amRNSPre-close Trading Update
24th Jun 20133:06 pmRNSChange of Auditor
24th Jun 20133:04 pmRNSResult of AGM
19th Jun 201310:40 amRNSNotice of Results
6th Jun 20136:13 pmRNSCirc re. Scrip Dividend
23rd May 20135:31 pmRNSNotice of AGM
17th May 20137:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.